![]() |
市場調查報告書
商品編碼
1735877
全球周邊血管設備產業2024-2029Peripheral Vascular Devices Industry, Global, 2024-2029 |
藥物釋放型支架和藥物塗層球囊創新推動轉型成長
Frost & Sullivan 預計,在預測期內,向藥物釋放型支架和藥物塗層球囊的轉變將成為推動周邊血管器械產業發展的主要趨勢。對生物可吸收支架的投資可能會進一步推動市場成長。藥物釋放型洗脫生物可吸收支架正日益受到業界相關人員的關注。此外,對開發周邊動脈疾病創新解決方案的興趣,尤其是膝下周邊動脈疾病和可能導致截肢的慢性缺血,將對市場成長產生積極影響。
本研究分析了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區的周邊血管裝置,例如金屬支架、生物可吸收支架、藥物釋放型支架、藥物塗層球囊、經皮血管成形術(PTA)球囊、導管等。研究提供了關於行業規模、成長率、成長機會、策略要務、患者治療途徑、公司市場佔有率、手術趨勢、新興技術和最終用戶的見解。
研究期間為2021-2029年,基準年為2024年,預測期間為2024-2029年。
Innovations in Drug-eluting Stents and Drug-coated Balloons are Driving Transformational Growth
Frost & Sullivan observes that the shift to drug-eluting stents and drug-coated balloons will be the key trends driving the peripheral vascular devices industry during the forecast period. Investments in bioresorbable scaffolds will further drive the market growth. Drug-eluting bioresorbable scaffolds are an area of interest among industry stakeholders. Moreover, interest in developing innovative solutions for peripheral artery disease, especially below-the-knee peripheral artery disease and complex chronic limb-threatening ischemia, positively impacts the market growth.
This study analyzes peripheral vascular devices, such as metal stents, bioresorbable stents, drug-eluting stents, drug-coated balloons, percutaneous transluminal angioplasty (PTA) balloons, and catheters. Regional coverage includes North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The study provides insights into industry size, growth rates, growth opportunities, strategic imperatives, patient pathways, company market share, procedure trends, new technologies, and end users.
The study period is from 2021 to 2029, the base year is 2024, and the forecast period is from 2024 to 2029.